Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ImmunoGen Inc.

ImmunoGen Announces Research Collaboration with Oxford BioTherapeutics to Develop Novel Antibody-Drug Conjugates
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2022 Operating Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Reports Recent Progress and 2021 Financial Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Conference Call to Discuss Its 2021 Operating Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Appoints Mimi Huizinga, MD, as Senior Vice President and Head of Medical Affairs
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Proposed Public Offering of Common Stock
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Appoints Kristen Harrington-Smith as Senior Vice President and Chief Commercial Officer
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Reports Recent Progress and Third Quarter 2021 Financial Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2021 Operating Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Appoints Helen M. Thackray, MD to its Board of Directors
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2021 Operating Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Mature Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Reports Recent Progress and First Quarter 2021 Financial Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2021 Operating Results
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
From ImmunoGen Inc.
Via Business Wire
Tickers IMGN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.